DeVane CL. Marijuana use in America: whither are we bound? Pharmacotherapy 2013;33(10):1009-11.
Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013;33(2):195-209.
Bowen LL, McRae-Clark AL. Therapeutic benefit of smoked cannabis in randomized placebo-controlled studies. Pharmacotherapy 2018;38(1):80-5.
Rhyne DN, Anderson SL, Gedde M, Borgelt LM. Effects of medical marijuana on migraine headache frequency in an adult population. Pharmacotherapy 2016;36(5):505-10.
Romero-Sandoval EA, Asbill S, Paige CA, Byrd-Glover K. Peripherally restricted cannabinoids for the treatment of pain. Pharmacotherapy 2015;35(10):917-25.
Romero-Sandoval EA, Ficham JE, Kolano AL, Sharpe BN, Alvardo-Vazquez PA. Cannabis for chronic pain: challenges and considerations. Pharmacotherapy 2018;38(6):651-62.
Fasinu PS, Phillips S, ElSohly MA, Walker LA. Current status and prospects for cannabidiol preparations as new therapeutic agents. Pharmacotherapy 2016;36(7):781-96.
Sherman BJ, McRae-Clark AL. Treatment of cannabis use disorder: Current science and future outlook. Pharmacotherapy 2016;36(5):511-35.
Richards JR, Gordon BK, Danielson AR, Moulin AK. Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review. Pharmacotherapy 2017;37(6):725-34.
Rech MA, Donahey D, Cappielo Dziedzic JM, Oh L, Greenhalgh E. New drugs of abuse. Pharmacotherapy 2015;35(2):189-97.
Armstrong F, McCurdy MT, Heavner MS. Synthetic cannabinoid-associated multiple organ failure: case series and literature review. Pharmacotherapy 2019;39(4):508-13.
